MDLN
Medline Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$36.59
+0.00%Year over year
Reported trailing growth
- Revenue
- +14.7%
- EBITDA
- -20.5%
- EBIT
- -21.4%
- EPS
- -46.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +8.0%
- EBITDA
- +35.5%
- EPS
- +72.0%
Three-year CAGR
- Revenue
- +9.9%
- EBITDA
- +1.7%
- EBIT
- +36.5%
- Net income
- +122.6%
- EPS
- +118.3%
- Free cash flow
- -3.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026